• Lead/Creatinine Ratio, Random, Urine
  • Endomysial (EMA) Antibody, IgG and IgM
  • Leukemia/Lymphoma Immunophenotyping by Flow Cytometry, Tissue
  • Bruton Tyrosine Kinase (BTK) Gene Mutation Analysis
  • Malignant neoplasm, pancreas
  • VDRL, Serum
  • Lipoprotein Associated Phospholipase A2 (PLAC)
  • Methyl CpG Binding Protein 2 (MECP2) Gene Mutation Analysis, Rett Syndrome
  • Prostate Cancer Antigen 3 (PCA3)
  • Chronic kidney disease
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Leukemia/Lymphoma Immunophenotyping by Flow Cytometry, Tissue
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Leukemia/Lymphoma Immunophenotyping by Flow Cytometry, Tissue
Medical Test

Turnaround Time
Access to Leukemia/Lymphoma Immunophenotyping by Flow Cytometry, Tissue is restricted.